Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04IIU
|
||||
Former ID |
DNC004666
|
||||
Drug Name |
INDISULAM
|
||||
Drug Type |
Small molecular drug
|
||||
Structure |
Download2D MOL |
||||
Formula |
C14H12ClN3O4S2
|
||||
InChI |
InChI=1S/C14H12ClN3O4S2/c15-12-8-17-14-11(12)2-1-3-13(14)18-24(21,22)10-6-4-9(5-7-10)23(16,19)20/h1-8,17-18H,(H2,16,19,20)
|
||||
InChIKey |
SETFNECMODOHTO-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9372911, 12015040, 14902746, 30420152, 46511460, 47206369, 49879993, 50885085, 53790787, 57399788, 103276735, 103832676, 113461710, 117631365, 126671562, 129225625, 134341871, 135135024, 137094473, 140360685, 165247707, 172821404, 176225599, 178103625, 179294234, 184527860, 198956059, 215780859, 223661106, 226469362, 252215593
|
||||
Target and Pathway | |||||
Target(s) | Carbonic anhydrase IX | Target Info | Modulator | ||
KEGG Pathway | Nitrogen metabolism | ||||
Pathway Interaction Database | HIF-1-alpha transcription factor network | ||||
References | |||||
Ref 521486 | ClinicalTrials.gov (NCT00014625) E7070 in Treating Patients With Stage IV Melanoma. U.S. National Institutes of Health. | ||||
Ref 542057 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7046). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.